Talampanel
CAS No. 161832-65-1
Talampanel ( GYKI-53773; LY-300164 )
Catalog No. M26835 CAS No. 161832-65-1
Talampanel is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor antagonist with anti-seizure activity.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
2MG | 49 | Get Quote |
|
5MG | 77 | Get Quote |
|
10MG | 111 | Get Quote |
|
25MG | 223 | Get Quote |
|
50MG | 370 | Get Quote |
|
100MG | 537 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTalampanel
-
NoteResearch use only, not for human use.
-
Brief DescriptionTalampanel is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor antagonist with anti-seizure activity.
-
DescriptionTalampanel is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor antagonist with anti-seizure activity. Talampanel (IVAX) has neuroprotective effects in rodent stroke models.(In Vivo):Talampanel (p.o.; 5 mg/kg; once a day; 2 weeks) decreases motoneuronal calcium in a mouse model of ALS .
-
SynonymsGYKI-53773; LY-300164
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorASK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number161832-65-1
-
Formula Weight337.4
-
Molecular FormulaC19H19N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@@H]1Cc2cc3OCOc3cc2C(=NN1C(C)=O)c1ccc(N)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(E/Z)-BCI
(E/Z)-BCI attenuates LPS-induced inflammatory mediators and ROS production in macrophage cells via activating the Nrf2 signaling axis and inhibiting the NF-κB pathway. (E/Z)-BCI is a dual-specificity phosphatase 6 (DUSP6) inhibitor with anti-inflammatory activities.
-
(-)-Epipodophyllotox...
(-)-Epipodophyllotoxin (2) is an antiproliferative agent against cancer cells with GI50s of 0.36 and 0.24 μM in HeLa cells and MCF-7 cells, respectively. (-)-Epipodophyllotoxin can inhibit mitotic spindle assembly in vitro.
-
DT2216
DT2216 inhibits various Bcl-XL-dependent leukemias and cancer cells, but is significantly less toxic to platelets.DT2216 is a selective B-cell lymphoma, extremely large (BCL-XL), proteolytic targeting chimera (PROTAC).